Last reviewed · How we verify

NCT04618926

A Comparison of Fiberoptic Endotracheal Intubation Between the Intubating Laryngeal Tube Suction and the LMA Protector

Status unknown Last updated 9 February 2021
What this trial tests

trial testing Device intubating Laryngeal Tube Suction Disposable in Difficult Airway in 80 participants. Status unknown.

Timeline
1 April 2021
Primary endpoint
1 October 2021
31 December 2021

Quick facts

Lead sponsorBnai Zion Medical Center
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment80
Start date1 April 2021
Primary completion1 October 2021
Estimated completion31 December 2021

Drugs / interventions tested

Conditions studied

Sponsor

Bnai Zion Medical Center

Who can join

Adults 18 to 75, any sex, with Difficult Airway. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Securing the airway is a pivotal skill for anesthesiologists and emergency care providers. Endotracheal intubation (ETI) is considered the gold standard for securing the airway. When ETI via laryngoscopy has failed, the use of a supraglottic airway device (SGAD) has been recommended. The intubating Laryngeal Tube Suction-Disposable and the LMA Protector are a new step in the evolution of supraglottic airways. Both SGADs are enable to ventilation and oxygenation, but the ventilation channel allow the insertion of an endotracheal tube and the use of fiberoptic bronchoscope. The aim of this study is to compare the time of fiberoptic intubation through the intubating Laryngeal Tube Suction Disposable and the LMA Protector in adult patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Difficult Airway

Currently open trials in the same condition.

Other Bnai Zion Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04618926.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing